le sémaglutide Semaglutide for weight loss | Blog Novo Nordisk's semaglutide shortage officially

However, prescribing decisions should align with FDA-approved indications and current clinical guidelines

Being upfront about things like thyroid disease, gallbladder issues, or past mental health concerns helps clinicians tailor treatment more safely

Phase 2 trial data showed mean body weight reductions of approximately 24% over 48 weeks at the highest dose in adults with obesity without type 2 diabetes

Kraft M, Kraft K, Grtner S, Mayerle J, Simon P, Weber E, Schtte K, Stieler J, Koula-Jenik H, Holzhauer P, Grber U, Engel G, Mller C, Feng YS, Aghdassi A, Nitsche C, Malfertheiner P, Patrzyk M, Kohlmann T, Lerch MM